Metabotropic glutamate receptors as drug targets: what's new?

Ferdinando Nicoletti,Valeria Bruno,Richard Teke Ngomba,Roberto Gradini,Giuseppe Battaglia

Current Opinion in Pharmacology（2015）

引用 80|浏览15

暂无评分

摘要

•There is still hope for a clinical use of mGlu ligands.•Targeted disorders may still include schizophrenia and Parkinson's disease.•Other disorders, such as SCA1 and absence epilepsy might be treated with mGlu drugs.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要